Ceftriaxone penetration into heart tissues (valves, myocardium, auricl
es and pericardium) and mediastinal tissues (fat and sternal bone) was
evaluated after two regimens of ceftriaxone administration, Ten patie
nts were given 1,000 g intravenously of ceftriaxone 30 min. before ane
sthesia. Ten other patients received the same dose and then a second 1
,000 mg dose at the time of initiation of cardiopulmonary bypass. Simi
lar and very satisfactory ceftriaxone tissue penetrations were observe
d in both groups. However, for some patients in the two groups and mai
nly in the sternal bone at the time of thorax closure, ceftriaxone lev
els in tissues were less than the MICs for some potential pathogens (M
ethicillin susceptible Staphylococcus aureus and Staphylococcus epider
midis). During the different steps of the surgical procedures all pati
ents in both groups had tissue levels greater than the MICs for Gram n
egative aerobic bacilli, except for Pseudomonas spp.